Trial intelligence / Profile preview

Paracervical block versus rectal diclofenac for pain relief during diagnostic hysteroscopy

PACTR202303663072593Phase 2Completed

Sponsor
Duru Victor Chinazom
Start
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of diclofenac and lidocaine (2 arms), sponsored by Duru Victor Chinazom. Primary endpoint: Mean pain score during diagnostic hysteroscopy. Started Apr 2023; status: completed.

02

Drugs

diclofenaclidocaine

Beyond the preview

Go deeper on PACTR202303663072593.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202303663072593.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call